Biologic Medicines & Bioprocessing

This basket pairs developers of biologic medicines with the laboratory and bioprocessing suppliers that support their development and manufacture. The focus is complex medicines and their production ecosystem, rather than healthcare delivery or a general drug-pipeline basket. Upcoming earnings provide an opportunity to assess whether medicine demand and research spending are translating into durable cash generation; reimbursement pressure and uneven laboratory spending remain risks. Launch basket (equal weight): ABBV, AMGN, MRK, LLY, TMO, DHR Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.